Contents
29 Clinical ambitions for APAC Komtur Pharmaceuticals Group
30 A purpose-built depot for European clinical trials Yourway
Temperature control
32 A hot-headed decision The process of transporting pharmaceutical products to clinical trials has many moving parts, all of which bring potential risk. Between the pharma companies, their logistics partners and their packaging suppliers, there is a burden of responsibility to maintain the cold chain and choose the right blend of active and passive cooling equipment to ensure substances arrive in perfect condition. Jim Banks talks to Temidayo Akenroye, associate professor of supply chain management and analytics at the University of Missouri-Saint Louis, to learn what factors must be assessed when choosing a container for cooling and some of the innovations that could soon lower the risk and reduce a company’s carbon footprint.
Outsourcing
35 Central intelligence Central laboratories have become a crucial part of running global and multi-regional clinical trials. Drug developers place a great deal of trust in these partner organisations,
32 Clinical Trials Insight /
www.worldpharmaceuticals.net
which carry out key processes like testing and specimen management. Sarah Harris asks Christina Hamilton, senior clinical research assistant at Caritas Science Solutions, and Tara Lehner, vice-president of clinical operations at INmune BIO, what they look for in a central laboratory when partnering for clinical trials.
39 The challenges in effective vendor management Lumis Life Science
Data management
40 Augmented in AI The process of organising and running a clinical trial comes with
several challenges, and a significant portion of the cost can be attributed to the operational conduct of the trial. This includes things like patient recruitment, site monitoring, data management and site oversight. There are digital tools to assist with these processes, but many in the industry are touting the benefits of AI to help trials to run smoother. Monica Karpinski speaks to Stefan Harrer, chief innovation officer at Digital Health Cooperative Research Centre and Aldo Faisal, professor of AI and neuroscience at Imperial College London, to delve into the details on the application of AI to optimise clinical trials.
35 40 5
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45
